Results
1
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
EZZ Life Science Holdings
Market Cap: AU$68.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$1.45
7D
4.1%
1Y
-52.2%